Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by 44 adaptive and innate immune system dysregulation. Recent work has revealed moderate 45 alteration of gut microbial communities in subjects with MS and in experimental, induced 46 models. However, a mechanistic understanding linking the observed changes in the microbiota 47 and the presence of the disease is still missing. Chloroform-resistant, spore-forming bacteria 48 have been shown to exhibit immunomodulatory properties in vitro and in vivo, but they have not 49 yet been characterized in the context of human disease. This study addresses the community 50 composition and immune function of this bacterial fraction in MS. We identify MS-associated 51 spore-forming taxa and show that their presence correlates with impaired differentiation of IL-10 52 secreting, regulatory T lymphocytes in-vitro. Colonization of antibiotic-treated mice with spore-53 forming bacteria allowed us to identify some bacterial taxa favoring IL-10 + lymphocyte 54 differentiation and others inducing differentiation of pro-inflammatory, IFN + T lymphocytes. 55
Introduction 76 77
The human gut microbiota is emerging as a major immune regulator in health and disease, 78 particularly in relation to autoimmune disorders. Most human microbiota studies to date have 79 been based on unbiased exploration of complete microbial communities. However, limited 80 sequencing depth, combined with high community richness and natural sample heterogeneity, 81 might hinder the discovery of physiologically relevant taxonomical differences. Thus, targeted 82 studies of specific microbial populations with defined characteristics may serve as a 83 complementary approach to investigate disease-associated changes in gut microbiome. 84 85 Spore-forming bacteria constitute a subset of Gram-positive bacteria that are resistant to 3% 86 chloroform treatment (1, 2). Both human and mouse spore-forming bacteria have 87 immunoregulatory functions (3, 4) . Mouse spore-forming bacteria include segmented 88 filamentous bacteria and Clostridia species, which have been shown to induce gut T helper 89 lymphocyte responses (3, 5). More recently, human spore-forming bacteria from a healthy 90 subject were also reported to induce Tregs in vitro and in gnotobiotic mice (4). However, 91 whether the composition and functions of spore-forming bacteria are altered in immune mediated 92 diseases is unknown. 93 94 Multiple sclerosis (MS) is a chronic disease of the central nervous system, characterized by 95 autoimmune destruction of myelin. MS pathogenesis is in part mediated by effector T 96 lymphocytes, and counterbalanced by Tregs, that limit the autoimmune damage inflicted by the 97 former population (6, 7) and potentially promote remyelination (8). Recent studies, including our 98 own, associated MS with moderate changes in the relative amounts of gut microbiota that 99 exacerbate T lymphocyte-mediated inflammation in vitro and in vivo by stimulating pro-100 inflammatory IFN+ Th1 and inhibiting IL-10+ regulatory T lymphocytes (9, 10). 101 102 We hypothesized that these MS-associated changes in gut microbial communities may involve 103 spore-forming bacteria thus altering its overall immunoregulatory properties. To address this 104 hypothesis, we isolated spore-forming bacteria from untreated patients with relapsing-remitting 105 MS (RRMS) and matched controls and analyzed their community composition and 106 7 Tregs that still differentiated in response to MS bacteria, retained their suppressive capacities in 143 vitro ( Fig. 2E ), thereby indicating that this was a functionally active population. Interestingly, the 144 percentage of IL-10+ Tregs induced by extracts of spore-forming bacteria positively correlated 145 with the relative abundance of Bacilli and negatively correlated with the relative abundance of 146 Clostridia (Fig. 2 F, expressed as Clostridia-Bacilli difference). Thus, the community 147 composition of spore-forming bacteria (i.e. high Clostridia, low Bacilli) associated with MS was 148 also correlated with an inhibition of their respective immunoregulatory functions. 149 150
Gnotobiotic mouse models reveal associations between individual bacterial taxa and T 151 lymphocyte responses 152
To determine whether the MS-associated reduction in the ability of spore-forming bacteria to 153 stimulate Treg differentiation was physiologically significant, we colonized a group of female 154 antibiotic-treated mice (21) with spore-forming bacteria from either controls (n=2) or MS 155 subjects (n=2) and measured the course and severity of EAE. We observed a significant 156 reduction in disease severity in all mice whose GI tracts were reconstituted with spore-forming 157 bacteria. However, this reduction was independent of whether the spore-forming fraction was 158 isolated from MS or controls ( Fig. 3 A) . This indicated that while MS-derived spore-forming 159 bacteria could be functionally distinguished in vitro, these differences were not sufficient to 160 induce a phenotype in vivo in our experimental setting. 161
162
We next analyzed whether spore-forming bacteria regulated T lymphocyte responses in vivo. To 163 this end we colonized antibiotic-treated mice with spore-forming bacteria from 3 controls and 3 164 MS patients and analyzed the resulting changes in bacterial composition and T lymphocyte 165 differentiation. Principal coordinate analysis (PCoA) of the beta diversity of gut microbiota 166 separated SPF mice from antibiotic-treated and colonized (i.e. gnotobiotic) mice. While no major 167 shifts in community composition based on disease state of the donor were observed ( Fig. 3B) , 168 multiple microbial taxa were differentially abundant ( Fig. 3C Further investigation identified individual taxa that were classified as either pro-inflammatory or 173 anti-inflammatory-based on the correlation between their relative abundance in mouse stool 174 samples and their ability to alter differentiation of IFN+ Th1 or IL-10+ regulatory lymphocytes 175 from either spleen or mesenteric lymph nodes (MLN) in vitro (Fig. 3D, 3E ). The pro-176 inflammatory category ( Fig. 3D , red rectangle) included taxa significantly increased in mice 177 colonized with spore-forming bacteria from MS patients compared to controls (highlighted in 178 red), while the anti-inflammatory category (mostly evident in splenocytes; blue rectangle) 179 contained taxa significantly reduced in mice colonized with spore-forming bacteria from MS 180 patients (highlighted in blue). 181
182
The increase in Akkermansia muciniphila, a non-spore-forming bacteria, in gnotobiotic mice 183 colonized with spore-forming bacteria from MS patients led to the hypothesis that spore-forming 184 bacteria may regulate Akkermansia levels. The correlation between spore-forming community 185 composition and relative abundance of Akkermansia is shown in Fig. 4A . The increase in 186
Akkermansia was present not only in the mice colonized with spore-forming bacteria from MS 187 donors, but also in MS donors themselves (p = 1.5E -09 , negative binomial Wald test) ( The spore-forming fraction of gut bacteria has been associated with immunoregulatory properties 201 (4). Here we examined the structural composition and immunological effects of the spore-202 forming fraction of gut microbiota from subjects with MS compared to controls. MS-associated 203 differences in bacterial community composition were correlated with impaired anti-inflammatory 204 functions, as evidenced by a reduction in their ability to drive T lymphocyte differentiation into 205 IL-10+ Tregs in vitro. Meanwhile, colonizing antibiotic-treated mice with spore-forming 206 bacteria allowed us to identify specific taxa correlated with T lymphocyte differentiation into 207 IFN+ and IL-10+ subtypes in vivo. 208
209
Our results contribute to the evidence supporting the immunoregulatory functions of spore-210 forming bacteria and show that these functions may be compromised in the context of 211 autoimmunity. Previous studies on spore-forming bacteria had been conducted by isolating this 212 fraction from a single healthy donor (4, 22). This approach allowed focusing on donor-specific 213 bacterial strains, but provided limited information about the "baseline" composition and 214 variability of this bacterial community in healthy humans. Here we used multiple healthy control 215 donors to establish the baseline community composition of spore-forming bacteria, and 216 compared these healthy profiles with those from patients with MS. 217 218 Our data corroborate previous findings that spore-forming bacteria, almost exclusively belonging 219 to the phylum Firmicutes, and classes Clostridia and Bacilli, induce anti-inflammatory T 220 lymphocytes in vitro and protect from autoimmune inflammation in vivo (4, 5). We also show 221 that the taxonomical distribution and immunoregulatory functions of spore-forming bacteria are 222 altered in MS patients. While were able to show that these differences have functional 223 consequences in-vitro, they were not sufficient to alter the course of EAE using antibiotic treated 224 mice. One possible explanation for this counterintuitive finding is that since our mice were 225 treated with antibiotics, they were not completely germ-free prior to colonization. As a 226 consequence, unexpected interactions among antibiotic resistant communities and the spore-227 forming fraction may have influenced the course of EAE. We recognize that using GF mice for 228 these experiments could address some of these concerns. However, raising GF animals is still a 229 highly specialized enterprise only available at select institutions. Further studies of gene 230 expression and metabolic output of spore-forming bacteria may provide therapeutic targets for 231 regulating T lymphocyte responses to reduce autoimmune inflammation. 232
233
The mechanisms by which spore-forming bacteria regulate host T lymphocyte differentiation 234 remain to be discovered. Interestingly, an overlapping subset of bacterial taxa has recently been 235 shown to inhibit host proteases, including cathepsins (23), which mediate adaptive immune 236 responses by increasing Th17 (24) 248 Akkermansia muciniphila has previously been reported to be increased in MS patients compared 249 to controls (9, 10, 29) and to have pro-inflammatory functions in vitro (10). In addition, 250
Akkermansia has been shown to be resistant to broad-spectrum antibiotics (30), which in part 251 may explain its persistence in mice colonized with spore-forming bacteria. The fact that high 252 levels of Akkermansia were only seen in mice colonized with MS chloroform-resistant bacteria 253 suggests that its population is normally regulated by commensals that are depleted in MS thus 254 enabling Akkermansia overgrowth. Analysis was performed using QIIME v1.9 as described (12). Essentially, amplicon sequences 318 were quality-filtered and grouped to "species-level" OTUs via SortMeRNA method (13), using 319
Greengenes v.13.8 97% dataset for closed reference. Sequences that did not match reference 320 sequences in the Greengenes database were dropped from analysis. Taxonomy was assigned to 321 the retained OTUs based on the Greengenes reference sequence, and the Greengenes tree was 322 used for all downstream phylogenetic community comparisons. OTUs were filtered to retain 323 only OTUs present in at least 5% of samples and covering at least 100 total reads. After filtering, 324 samples were rarefied to 10000 sequences per sample. Alpha diversity was calculated using the 325 Chao1 method (14). For analysis of beta diversity, pairwise distance matrices were generated 326 using the phylogenetic metric unweighted UniFrac (15) and used for principal coordinate 327 analysis (PCoA). For comparison of individual taxa, samples were not rarefied. Instead, OTU 328 abundances were normalized using variance-stabilizing transformation and taxa distributions 329 were compared using Wald negative binomial test from R software package DESeq2 as 330 described previously (16, 17) with Benjamini-Hochberg correction for multiple comparisons. 331
Linear correlations between bacterial taxa and lymphocyte proportions were computed after 332 variance-stabilizing transformation of bacterial abundances (16). 333 334
Mouse colonization with microbiota 335
Female littermates 5 week old C57BL/6J mice (JAX #000664) were treated with 1% solution of 336 Amphotericin B in drinking water for 3 days, followed by 2 weeks of a solution composed of 1% 337 Amphotericin B, 1mg/ml ampicillin, 1mg/ml neomycin, 1mg/ml metronidazole and 0.5mg/ml 338 vancomycin in drinking water. After 2 weeks, the drinking solution was replaced by sterile water 339 and mice were gavaged with specific bacteria of interest at 2*10^8 CFU in 100ul per mouse 340 every 2 days for 2 weeks (7 total gavages). Bacterial colonization was either followed by the 341 induction of EAE or immunophenotyping of mesenteric and cervical lymph nodes. Human peripheral blood mononuclear cells were isolated from healthy volunteers and stored at -360 80° C in cryovials at 10^7 cells/ml concentration in FBS containing 10% DMSO. Before plating, 361 cells were washed in PBS twice, re-counted, and plated at 10^6 cells/ml concentration in RPMI 362 media supplemented with 10% FBS and 1% penicillin/streptomycin/glutamine. Cells were 363 stimulated for 3 days as described previously (18) with anti-human CD3 (BD #555336, 0.3 364 µg/ml), anti-human CD28 (BD #555725, 2 µg/ml) and recombinant human TGF-1 (R&D 365 #240B002, 2.5ng/ml). 366 367 Bacteria isolated from human chloroform-resistant cultures were resuspended in PBS 368 supplemented with protease inhibitor (Roche #4693159001) and phosphatase inhibitor (Roche 369 #4906845001), heat-inactivated at 65° C for 1h and sonicated for 10min as described previously 370 (19) . Protein concentration in the resulting suspension was measured using the Pierce BCA 371 protein assay kit (Thermo Scientific #23227). Bacterial extracts were added to PBMCs at 1µg/ml 372 1h after plating as described previously (20) . PBS with the same protease inhibitor and 373 phosphatase inhibitor was added as the no-bacteria control. Each human in vitro experiment 374 contained at least 6 independent donor bacterial samples and was repeated at least twice. 375 376
Immunostaining, flow cytometry and FACS of human immune cells 377
Human PBMCs were immunostained using standard protocols. Live/dead cell gating was 378 achieved using Live/Dead Fixable Aqua kit (ThermoFisher #L34957). FoxP3/transcription factor 379 staining buffer set (eBioscience #00-5523-00) was used for staining of intracellular and 380 intranuclear cytokines. The following antibodies were used for human PBMC staining: anti-381 CD3-PE.Cy7 (BD #563423), anti-CD4-PerCP.Cy5.5 (BioLegend #300530), anti-CD25-APC 382 (BD #555434), anti-FoxP3-AlexaFluor488 (BD #560047) and anti-IL-10-PE (eBioscience #12-383 7108). 
